The HSJ Awards recognise the outstanding contributions made to healthcare across the UK and showcase these achievements on a national platform.
The Hepatitis C Drug Treatment Services (DTS) Provider Forum has been nominated for its ‘Hepatitis C Virus Screening in Drug Treatment Services’ initiative, which aims to eliminate hepatitis C from UK drug and alcohol services by the end of 2023.
Membership of the Provider Forum includes a collection of the UK’s leading drug and alcohol service providers and The Hepatitis C Trust. The group’s members have been working together to implement a collaborative reporting and monitoring approach in hepatitis C test and treat data.
Marlon Freeman, hep C coordinator at WDP said: “Raising awareness of Hepatitis C and the very real potential to eliminate it is key to delivering the ambitions of this project. We’re really proud of the partnership and what has been delivered so far. Being shortlisted for this award provides another important platform to promote this life-saving initiative.”
HSJ editor Alastair McLellan, added, “On behalf of all my colleagues, it gives me great pleasure to congratulate Hepatitis C Drug Treatment Services (DTS) Provider Forum on being shortlisted as a finalist in the category of ‘Performance Recovery Award’. We’re all very much looking forward to welcoming our finalists to the awards ceremony in November, celebrating their impressive achievements and jointly acknowledging our values of sharing best practice, improving patient outcomes and continuously driving for better service.”
Read the full blog post here.
DDN magazine is a free publication self-funded through advertising.
We are proud to work in partnership with many of the leading charities and treatment providers in the sector.
This content was created by WDP